Robert Reiter, MD
Dr. Reiter is the Bing Professor of Urologic Oncology and Chief, Division of Urologic Oncology at UCLA. He is Principal Investigator on UCLA's Prostate Cancer SPORE. His research is focused on anatomical and molecular imaging of prostate cancer, as well as elucidation of the molecular mechanisms of prostate cancer progression.
Financial relationships
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:PfizerMitigation strategy:Peer reviewDate reviewed:10/24/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:LantheusMitigation strategy:Peer reviewDate reviewed:10/24/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Oncology)Ineligible company:Point biopharmaMitigation strategy:Peer reviewDate reviewed:10/24/2022
-
Attribution:SelfType of financial relationship:Meeting Participant or Lecturer (Oncology)Ineligible company:BayerMitigation strategy:Peer reviewDate reviewed:10/24/2022
-
Attribution:SelfType of financial relationship:Meeting Participant or Lecturer (Specialty Not Specified)Ineligible company:Genomic HealthMitigation strategy:Peer reviewDate reviewed:10/24/2022
-
Attribution:SelfType of financial relationship:Consultant or Advisor (Specialty Not Specified)Ineligible company:JanssenMitigation strategy:Peer reviewDate reviewed:10/24/2022
-
Attribution:SelfType of financial relationship:Investment Interest (Specialty Not Specified)Ineligible company:ImaginAb CorporationMitigation strategy:Peer reviewDate reviewed:10/24/2022